Abingworth as of March 31, 2016
Portfolio Holdings for Abingworth
Abingworth holds 19 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Paratek Common | 18.3 | $20M | 1.3M | 15.14 | |
| Chiasma Common | 17.7 | $19M | 2.1M | 9.15 | |
| Proteon Common | 14.5 | $16M | 2.0M | 7.71 | |
| Sientra Common | 14.0 | $15M | 2.2M | 6.84 | |
| Cempra Common | 6.2 | $6.7M | 384k | 17.51 | |
| Dicerna Common | 4.7 | $5.1M | 946k | 5.35 | |
| Tobira Common | 4.4 | $4.8M | 589k | 8.12 | |
| Innocoll Sponds Adr | 4.3 | $4.7M | 556k | 8.40 | |
| Lombard Medical Common (EVARF) | 3.5 | $3.8M | 3.5M | 1.08 | |
| Cellectis Sponds Adr (CLLS) | 2.5 | $2.7M | 100k | 27.35 | |
| Regulus Common | 2.1 | $2.3M | 327k | 6.92 | |
| Cymabay Common | 2.0 | $2.2M | 1.6M | 1.35 | |
| Adaptimmune Sponds Adr (ADAP) | 1.9 | $2.0M | 250k | 8.11 | |
| Anthera Common | 1.5 | $1.6M | 438k | 3.60 | |
| Dermira Common | 1.3 | $1.4M | 70k | 20.69 | |
| ChemoCentryx Common | 0.5 | $533k | 215k | 2.48 | |
| Oncogenex Pharma Common | 0.3 | $271k | 396k | 0.68 | |
| Aurinia Pharma Common (AUPH) | 0.2 | $256k | 88k | 2.90 | |
| Epirus Biopharma Common (EPRSQ) | 0.0 | $21k | 7.9k | 2.66 |
